Validamycin A

Tổng quan IFRA Báo giá

  • Định danh

    Số CAS
    37248-47-8

    Công thức phân tử
    C20H35NO13

    SMILES
    C1[C@@H]([C@H]([C@@H]([C@H]([C@H]1N[C@H]2C=C([C@H]([C@@H]([C@H]2O)O)O)CO)O)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)CO

    Nhãn an toàn

    Irritant
    Kích ứng

  • Hồ sơ mùi hương

    Hương thơm
    Không mùi 74.06%
    Ngọt 41.11%
    Cồn 21.66%
    Thơm ngon 17.83%
    Mát lạnh 17.64%
    Tanh cá 16.61%
    Gỗ 16.32%
    Caramel 16.14%
    Đắng 16.06%
    Vani 15.7%

     

    Hương vị
    Sweet 65.68%
    Odorless 52.69%
    Bitter 51.01%
    Sweet-like 31.96%
    Cauliflower 21.43%
    Very slight 21.38%
    Fatty 21.04%
    Bland 20.97%
    Alkaline 20.54%
    Very mild 20.24%

     

    Cường độ mùi ước lượng
    Thấp

  • Thuộc tính

    XLogP3-AA
    -6.3

    pKa ước lượng
    5.06 (axit yếu)

    Khối lượng phân tử
    497.5 g/mol

    Áp suất hơi ước lượng

    • hPa @ 20°C
    • hPa @ 25°C

    Tốc độ bay hơi
    Tương đối nhanh

    Điểm sôi ước lượng
    3906°C

    Điểm tan chảy thực nghiệm

    • 130-135 °C (with decomp)

    Điểm chớp cháy

    • 312.97 ˚C ước lượng

    Độ tan thực nghiệm

    • Solubility: very soluble in water; soluble in dimethylformamide, dimethyl sulphoxide, methanol; sparingly soluble in acetone, ethanol.
    • Sparingly soluble in diethyl ether and ethyl acetate.

  • Các tên gọi

    • Validamycin
    • VALIDAMYCIN A
    • 37248-47-8
    • Validacin
    • Valimon
    • UNII-313E9620QS
    • CHEBI:29703
    • HSDB 6745
    • 313E9620QS
    • T-7545-A
    • VALIDAMYCIN A [HSDB]
    • (2R,3R,4S,5S,6R)-2-[(1R,2R,3S,4S,6R)-2,3-dihydroxy-6-(hydroxymethyl)-4-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]cyclohexyl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
    • DTXSID4058073
    • VALIDAMYCINS VALIDAMYCIN A [MI]
    • (1S-(1a,4a,5B,6a))-1,5,6-Trideoxy-3-O-B-D-glucopyranosyl-5-(hydroxymethyl)-1-((4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-d-chiro-inositol
    • (1S-(1alpha,4alpha,5beta,6alpha))-1,5,6-trideoxy-4-O-beta-D-glucopyranosyl-5-(hydroxymethyl)-1-((4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-D-chiro-inositol
    • 1L-(1,3,4/2,6)-2,3-Dihydroxy-6-hydromethyl-4-((1S,4R,5S,6S)-4,5,6-trihydroxy-3-hydroxymethylcyclohex-2-enylamino)cyclohexyl beta-D-glucopyranoside
    • 1L-(1,3,4/2,6)-2,3-Dihydroxy-6-hydroxymethyl-4-((1S,4R,5S,6S)-4,5,6-trihydroxy-3-hydroxymethylcyclohex-2-enylamino)cyclohexyl beta-D-glucopyranoside
    • D-1,5,6-Trideoxy-3-O-beta-D-glucopyranosyl-5-(hydroxymethyl)-1-((4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-D-chiroinositol
    • (1R,2R,3S,4S,6R)-2,3-dihydroxy-6-(hydroxymethyl)-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexyl beta-D-glucopyranoside
    • (2R,3R,4S,5S,6R)-2-[(1R,2R,3S,4S,6R)-2,3-dihydroxy-6-(hydroxymethyl)-4-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]cyclohexoxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
    • D-chiro-Inositol, 1,5,6-trideoxy-3-O-beta-D-glucopyranosyl-5-(hydroxymethyl)-1-((4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-, (1S-(1-alpha,4-alpha,5-beta,6-alpha))-
    • D-CHIRO-INOSITOL, 1,5,6-TRIDEOXY-4-O-.BETA.-D-GLUCOPYRANOSYL-5-(HYDROXYMETHYL)-1-(((1S,4R,5S,6S)-4,5,6-TRIHYDROXY-3-(HYDROXYMETHYL)-2-CYCLOHEXEN-1-YL)AMINO)-
    • D-CHIRO-INOSITOL, 1,5,6-TRIDEOXY-4-O-.BETA.-D-GLUCOPYRANOSYL-5-(HYDROXYMETHYL)-1-((4,5,6-TRIHYDROXY-3-(HYDROXYMETHYL)-2-CYCLOHEXEN-1-YL)AMINO)-, (1S-(1.ALPHA.,4.ALPHA.,5.BETA.,6.ALPHA.))-
    • Validamycin A (>70%) Hydrochloride Salt
    • Cepex 10SL; Validacin
    • Validamycin A Sulfate salt (Technical grade)
    • jinganmycin A
    • (1R,2R,3S,4S,6R)-2,3-dihydroxy-6-(hydroxymethyl)-4-(((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl)amino)cyclohexyl beta-D-glucopyranoside
    • (2R,3R,4S,5S,6R)-2-((1R,2R,3S,4S,6R)-2,3-dihydroxy-6-(hydroxymethyl)-4-(((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl)amino)cyclohexoxy)-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
    • (2R,5S)-2-((1R,2R,4S,6R)-2,3-dihydroxy-6-(hydroxymethyl)-4-(((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl)amino)cyclohexyl)oxy-6-(hydroxymethyl)oxane-3,4,5-triol
    • (2R,5S)-2-[(1R,2R,4S,6R)-2,3-dihydroxy-6-(hydroxymethyl)-4-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]cyclohexyl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
    • 1,5,6-Trideoxy-4-O-b-D-glucopyranosyl-5-(hydroxymethyl)-1-(((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-D-chiro-inositol
    • 1,5,6-Trideoxy-4-O-b-D-glucopyranosyl-5-(hydroxymethyl)-1-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-D-chiro-inositol
    • 1,5,6-Trideoxy-4-O-I2-D-glucopyranosyl-5-(hydroxymethyl)-1-(((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-D-chiro-inositol
    • 1,5,6-Trideoxy-4-O-I2-D-glucopyranosyl-5-(hydroxymethyl)-1-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-D-chiro-inositol
    • D-chiro-Inositol, 1,5,6-trideoxy-4-O-.beta.-D-glucopyranosyl-5-(hydroxymethyl)-1-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-
    • D-CHIRO-INOSITOL, 1,5,6-TRIDEOXY-4-O-BETA-D-GLUCOPYRANOSYL-5-(HYDROXYMETHYL)-1-(((1S,4R,5S,6S)-4,5,6-TRIHYDROXY-3-(HYDROXYMETHYL)-2-CYCLOHEXEN-1-YL)AMINO)-
    • D-chiro-Inositol, 1,5,6-trideoxy-4-O-beta-D-glucopyranosyl-5-(hydroxymethyl)-1-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-
    • MFCD09028089
    • (+)-validamycin A
    • Validamycin A (Standard)
    • SCHEMBL3121491
    • CHEMBL1923413
    • DTXCID0031841
    • HY-B0856R
    • VALIDAMYCINS VALIDAMYCIN A
    • JARYYMUOCXVXNK-CSLFJTBJSA-N
    • HY-B0856
    • T7545A
    • AKOS016012982
    • AG-F-30599
    • AV59477
    • AC-32607
    • AS-15281
    • CS-0012869
    • Validamycin A, PESTANAL(R), analytical standard
    • Validamycin; CE30; JARYYMUOCXVXNK-CSLFJTBJSA-N
    • D-Chiro-inositol,1,5,6-trideoxy-3-O-beta-D-glucopyranosyl-
    • (1S(1a,4a,5b,6a))1,5,6Trideoxy3ObDglucopyranosyl5(hydroxymethyl)1((4,5,6trihydroxy3(hydroxymethyl)2cyclohexen1yl)amino)Dchiroinositol
    • (1S(1alpha,4alpha,5beta,6alpha))1,5,6trideoxy4ObetaDglucopyranosyl5(hydroxymethyl)1((4,5,6trihydroxy3(hydroxymethyl)2cyclohexen1yl)amino)Dchiroinositol
    • (1S-(1 alpha, 4 alpha, 5 beta, 6 alpha))-1,5,6-trideoxy-4-O-beta-D-glucopyranosyl-5-(hydroxymethyl)-1-((4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-D-chiro-inositol
    • (1S-(1.ALPHA.,4.ALPHA.,5.BETA.,6.ALPHA.))-1,5,6-TRIDEOXY-4-O-.BETA.-D- GLUCOPYRANOSYL-5-(HYDROXYMETHYL)-1-((4,5,6-TRIHYDROXY-3- (HYDROXYMETHYL)-2-CYCLOHEXEN-1-YL)AMINO)-D-CHIRO-INOSITOL
    • (1S-(1A,4A,5B,6A))-1,5,6-TRIDEOXY-3-O-B-D-GLUCOPYRANOSYL-5- (HYDROXYMETHYL)-1-((4,5,6-TRIHYDROXY-3-(HYDROXYMETHYL)-2- CYCLOHEXEN-1-YL)AMINO)-D-CHIRO-INOSITOL
    • (1S-(1a,4a,5B,6a))-1,5,6-trideoxy-3-O-B-D-glucopyranosyl-5-(hydroxymethyl)-1-((4,5,6-trihydroxy-3-(hydroxymethyl)-=2-cyclohexen-1-yl)amino)-d-chiro-inositol
    • (1S-(1a,4a,5b,6a))-1,5,6-Trideoxy-4-O-b-D-glucopyranosyl-5-(hydroxymethyl)-1-((4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-D-chiro-inositol
    • (2R,3R,4S,5S,6R)-2-(((1R,2R,3S,4S,6R)-2,3-Dihydroxy-6-(hydroxymethyl)-4-(((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl)amino)cyclohexyl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
    • 1,5,6-trideoxy-4-O-beta-D-glucopyranosyl-5-(hydroxymethyl)-1-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-D-chiro-inositol
    • 1L(1,3,4/2,6)2,3Dihydroxy6hydromethyl4((1S,4R,5S,6S)4,5,6trihydroxy3hydroxymethylcyclohex2enylamino)cyclohexyl betaDglucopyranoside
    • 1L(1,3,4/2,6)2,3Dihydroxy6hydroxymethyl4((1S,4R,5S,6S)4,5,6trihydroxy3hydroxymethylcyclohex2enylamino)cyclohexyl betaDglucopyranoside
    • 1L-(1,3,4/2,6)-2,3-DIHYDROXY-6-HYDROMETHYL-4-((1S,4R,5S,6S)- 4,5,6-TRIHYDROXY-3-HYDROXYMETHYLCYCLOHEX-2- ENYLAMINO)CYCLOHEXYL .BETA.-D-GLUCOPYRANOSIDE
    • 1L-(1,3,4/2,6)-2,3-dihydroxy-6-hydromethyl-4-((1S,4R,5S,6S)-4,5,6-trihydroxy-3-hydroxymethylcyclohex-2-enylamino) cyclohexyl beta-D-glucopyranoside
    • 1L-(1,3,4/2,6)-2,3-DIHYDROXY-6-HYDROMETHYL-4-((1S,4R,5S,6S)-4,5,6-TRIHYDROXY-3-HYDROXYMETHYLCYCLOHEX-2-ENYLAMINO)CYCLOHEXYL .BETA.-D-GLUCOPYRANOSIDE
    • 1L-(1,3,4/2,6)-2,3-DIHYDROXY-6-HYDROXYMETHYL-4- ((1S,4R,5S,6S)-4,5,6-TRIHYDROXY-3-HYDROXYMETHYLCYCLOHEX-2- ENYLAMINO)CYCLOHEXYL .BETA.-D-GLUCOPYRANOSIDE
    • 1l-(1,3,4/2,6)-2,3-dihydroxy-6-hydroxymethyl-4-((1S,4R,5S,6S)-4,5,6-trihydroxy-3-hydroxymethylcyclohex-2-enylamino)cyclohexyl I2-D-glucopyranoside
    • 58194-43-7
    • 609-372-4
    • D-1,5,6-TRIDEOXY-3-O-.BETA.-D-GLUCOPYRANOSYL-5- (HYDROXYMETHYL)-1-((4,5,6-TRIHYDROXY-3-(HYDROXYMETHYL)-2- CYCLOHEXEN-1-YL)AMINO)-D-CHIROINOSITOL
    • D-1,5,6-Trideoxy-3-O-b-D-glucopyranosyl-5-(hydroxymethyl)-1-((4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-D-chiroinositol
    • D-1,5,6-Trideoxy-3-O-I2-D-glucopyranosyl-5-(hydroxymethyl)-1-((4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-D-chiroinositol
    • D-CHIRO-INOSITOL, 1,5,6-TRIDEOXY-3-O-.BETA.-D-GLUCOPYRANOSYL- 5-(HYDROXYMETHYL)-1-((4,5,6-TRIHYDROXY-3-(HYDROXYMETHYL)-2- CYCLOHEXEN-1-YL)AMINO)-, (1S-(1-.ALPHA.,4-.ALPHA.,5-.BETA.,6- .ALPHA.))-
    • D-CHIRO-INOSITOL, 1,5,6-TRIDEOXY-3-O-.BETA.-D-GLUCOPYRANOSYL-5-(HYDROXYMETHYL)-1-((4,5,6-TRIHYDROXY-3-(HYDROXYMETHYL)-2-CYCLOHEXEN-1-YL)AMINO)-, (1S-(1-.ALPHA.,4-.ALPHA.,5-.BETA.,6-.ALPHA.))-
    • D-CHIRO-INOSITOL, 1,5,6-TRIDEOXY-4-O-BETA-D-GLUCOPYRANOSYL-5-(HYDROXYMETHYL)-1-((4,5,6-TRIHYDROXY-3-(HYDROXYMETHYL)-2-CYCLOHEXEN-1-YL)AMINO)-, (1S-(1ALPHA,4ALPHA,5BETA,6ALPHA))-
    • D1,5,6Trideoxy3ObetaDglucopyranosyl5(hydroxymethyl)1((4,5,6trihydroxy3(hydroxymethyl)2cyclohexen1yl)amino)Dchiroinositol

  • Ứng dụng

    Validamycin A (CAS 37248-47-8) được sử dụng chủ yếu như một thuốc trừ nấm sinh học trong nông nghiệp để bảo vệ cây trồng trước các bệnh nấm gây hại, đặc biệt bệnh thối do Rhizoctonia solani ở lúa, bằng cách ức chế enzyme trehalase của nấm và làm gián đoạn quá trình sinh khối và năng lượng. Trong thực tế, nó được áp dụng như một fungicide bảo vệ cây trồng, thường được tích hợp vào các chương trình quản lý dịch hại tổng hợp với các xem xét về dạng bào chế và giới hạn quy định địa phương. Nó cũng được nghiên cứu như một biện pháp kiểm soát bệnh sau thu hoạch và bảo quản ngũ cốc trong kho. Ở môi trường nghiên cứu, nó đóng vai trò như một hợp chất công cụ để nghiên cứu trehalase và sinh lý nấm, và có thể được xem là một dẫn xuất tiềm năng cho phát triển các chất kháng nấm mới. Việc sử dụng phụ thuộc vào quy định địa phương và giới hạn công thức.

    gpt-5-nano

  • Độ tan @25˚C

    Dung môi Độ tan (g/L)
    ethanol 1.41
    methanol 4.1
    isopropanol 0.25
    water 44.19
    ethyl acetate 0.13
    n-propanol 0.44
    acetone 0.4
    n-butanol 0.3
    acetonitrile 0.15
    DMF 7.1
    toluene 0.08
    isobutanol 0.12
    1,4-dioxane 0.92
    methyl acetate 0.11
    THF 0.9
    2-butanone 0.21
    n-pentanol 0.12
    sec-butanol 0.16
    n-hexane 0.01
    ethylene glycol 11.93
    NMP 12.02
    cyclohexane 0.05
    DMSO 41.08
    n-butyl acetate 0.05
    n-octanol 0.14
    chloroform 0.04
    n-propyl acetate 0.04
    acetic acid 7.67
    dichloromethane 0.05
    cyclohexanone 0.55
    propylene glycol 4.93
    isopropyl acetate 0.08
    DMAc 6.28
    2-ethoxyethanol 2.2
    isopentanol 0.11
    n-heptane 0.04
    ethyl formate 0.22
    1,2-dichloroethane 0.06
    n-hexanol 0.15
    2-methoxyethanol 9.36
    isobutyl acetate 0.02
    tetrachloromethane 0.02
    n-pentyl acetate 0.1
    transcutol 3.82
    n-heptanol 0.23
    ethylbenzene 0.03
    MIBK 0.09
    2-propoxyethanol 1.61
    tert-butanol 0.11
    MTBE 0.04
    2-butoxyethanol 1.33
    propionic acid 0.73
    o-xylene 0.08
    formic acid 68.14
    diethyl ether 0.13
    m-xylene 0.07
    p-xylene 0.02
    chlorobenzene 0.02
    dimethyl carbonate 0.61
    n-octane 0.02
    formamide 38.71
    cyclopentanone 0.91
    2-pentanone 0.22
    anisole 0.06
    cyclopentyl methyl ether 0.39
    gamma-butyrolactone 1.09
    1-methoxy-2-propanol 3.54
    pyridine 0.49
    3-pentanone 0.19
    furfural 1.96
    n-dodecane 0.01
    diethylene glycol 6.1
    diisopropyl ether 0.03
    tert-amyl alcohol 0.11
    acetylacetone 0.52
    n-hexadecane 0.01
    acetophenone 0.14
    methyl propionate 0.32
    isopentyl acetate 0.03
    trichloroethylene 0.09
    n-nonanol 0.15
    cyclohexanol 0.34
    benzyl alcohol 0.22
    2-ethylhexanol 0.06
    isooctanol 0.11
    dipropyl ether 0.13
    1,2-dichlorobenzene 0.02
    ethyl lactate 0.31
    propylene carbonate 0.31
    n-methylformamide 3.99
    2-pentanol 0.13
    n-pentane 0.02
    1-propoxy-2-propanol 0.74
    1-methoxy-2-propyl acetate 0.32
    2-(2-methoxypropoxy) propanol 0.75
    mesitylene 0.04
    ε-caprolactone 0.54
    p-cymene 0.03
    epichlorohydrin 0.54
    1,1,1-trichloroethane 0.01
    2-aminoethanol 7.11
    morpholine-4-carbaldehyde 9.11
    sulfolane 6.24
    2,2,4-trimethylpentane 0.01
    2-methyltetrahydrofuran 0.26
    n-hexyl acetate 0.1
    isooctane 0.0
    2-(2-butoxyethoxy)ethanol 1.66
    sec-butyl acetate 0.03
    tert-butyl acetate 0.08
    decalin 0.01
    glycerin 27.8
    diglyme 2.4
    acrylic acid 1.93
    isopropyl myristate 0.03
    n-butyric acid 0.56
    acetyl acetate 0.15
    di(2-ethylhexyl) phthalate 0.08
    ethyl propionate 0.07
    nitromethane 3.95
    1,2-diethoxyethane 0.23
    benzonitrile 0.06
    trioctyl phosphate 0.07
    1-bromopropane 0.03
    gamma-valerolactone 3.63
    n-decanol 0.1
    triethyl phosphate 0.07
    4-methyl-2-pentanol 0.05
    propionitrile 0.06
    vinylene carbonate 0.35
    1,1,2-trichlorotrifluoroethane 3.51
    DMS 0.16
    cumene 0.02
    2-octanol 0.1
    2-hexanone 0.06
    octyl acetate 0.07
    limonene 0.05
    1,2-dimethoxyethane 0.88
    ethyl orthosilicate 0.07
    tributyl phosphate 0.05
    diacetone alcohol 0.59
    N,N-dimethylaniline 0.1
    acrylonitrile 0.17
    aniline 0.27
    1,3-propanediol 4.75
    bromobenzene 0.01
    dibromomethane 0.03
    1,1,2,2-tetrachloroethane 0.1
    2-methyl-cyclohexyl acetate 0.05
    tetrabutyl urea 0.14
    diisobutyl methanol 0.04
    2-phenylethanol 0.17
    styrene 0.03
    dioctyl adipate 0.07
    dimethyl sulfate 2.08
    ethyl butyrate 0.06
    methyl lactate 2.21
    butyl lactate 0.3
    diethyl carbonate 0.04
    propanediol butyl ether 1.83
    triethyl orthoformate 0.09
    p-tert-butyltoluene 0.03
    methyl 4-tert-butylbenzoate 0.34
    morpholine 1.67
    tert-butylamine 0.04
    n-dodecanol 0.07
    dimethoxymethane 2.28
    ethylene carbonate 0.23
    cyrene 2.07
    2-ethoxyethyl acetate 0.27
    2-ethylhexyl acetate 0.03
    1,2,4-trichlorobenzene 0.03
    4-methylpyridine 0.2
    dibutyl ether 0.06
    2,6-dimethyl-4-heptanol 0.04
    DEF 0.91
    dimethyl isosorbide 1.12
    tetrachloroethylene 0.14
    eugenol 0.48
    triacetin 0.27
    span 80 0.96
    1,4-butanediol 1.13
    1,1-dichloroethane 0.02
    2-methyl-1-pentanol 0.06
    methyl formate 2.02
    2-methyl-1-butanol 0.13
    n-decane 0.02
    butyronitrile 0.06
    3,7-dimethyl-1-octanol 0.05
    1-chlorooctane 0.04
    1-chlorotetradecane 0.01
    n-nonane 0.02
    undecane 0.01
    tert-butylcyclohexane 0.0
    cyclooctane 0.04
    cyclopentanol 0.43
    tetrahydropyran 0.3
    tert-amyl methyl ether 0.07
    2,5,8-trioxanonane 2.0
    1-hexene 0.02
    2-isopropoxyethanol 0.62
    2,2,2-trifluoroethanol 4.18
    methyl butyrate 0.09

    Scent© AI

1 4

Tiêu chuẩn IFRA 51

Đề nghị
Không hạn chế
Nồng độ tối đa được chấp nhận trong sản phẩm hoàn thiện (%)
Danh mục 1
Sản phẩm sử dụng cho môi
 Không hạn chế Danh mục 7A
Sản phẩm rửa xả thoa lên tóc có tiếp xúc với tay
 Không hạn chế
Danh mục 2
Sản phẩm sử dụng cho vùng nách
 Không hạn chế Danh mục 7B
Sản phẩm lưu lại trên tóc có tiếp xúc với tay
 Không hạn chế
Danh mục 3
Sản phẩm thoa lên mặt/cơ thể bằng đầu ngón tay
 Không hạn chế Danh mục 8
Sản phẩm có tiếp xúc đáng kể với vùng hậu môn - sinh dục
 Không hạn chế
Danh mục 4
Sản phẩm liên quan đến nước hoa
 Không hạn chế Danh mục 9
Sản phẩm tiếp xúc với cơ thể và tay, chủ yếu rửa xả
 Không hạn chế
Danh mục 5A
Sản phẩm dưỡng thể thoa lên cơ thể bằng tay (lòng bàn tay), chủ yếu lưu lại trên da
 Không hạn chế Danh mục 10A
Sản phẩm chăm sóc nhà cửa chủ yếu tiếp xúc với tay
 Không hạn chế
Danh mục 5B
Sản phẩm dưỡng ẩm cho mặt thoa lên mặt bằng tay (lòng bàn tay), chủ yếu lưu lại trên da
 Không hạn chế Danh mục 10B
Sản phẩm chăm sóc nhà cửa chủ yếu tiếp xúc với tay, bao gồm dạng xịt/phun (có khả năng lưu lại trên da)
 Không hạn chế
Danh mục 5C
Kem dưỡng da tay thoa lên tay bằng tay (lòng bàn tay), chủ yếu lưu lại trên da
 Không hạn chế Danh mục 11A
Sản phẩm dự kiến tiếp xúc với da nhưng hầu như không truyền hương lên da từ chất nền trơ, không tiếp xúc với tia UV
 Không hạn chế
Danh mục 5D
Kem dưỡng, dầu dưỡng và phấn rôm cho em bé
 Không hạn chế Danh mục 11B
Sản phẩm dự kiến tiếp xúc với da nhưng hầu như không truyền hương lên da từ chất nền trơ, có khả năng tiếp xúc với tia UV
 Không hạn chế
Danh mục 6
Sản phẩm tiếp xúc với miệng và môi
 Không hạn chế Danh mục 12
Sản phẩm không nhằm tiếp xúc trực tiếp với da, chỉ truyền rất ít hoặc không đáng kể sang da
 Không hạn chế